Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

NIST physical standards for DNA-based medical testing.

Peter E Barker¹, Michael S Watson, John R Ticehurst

¹NCI-NIST Biomarkers Validation Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899-8311, USA.

Journal of Clinical Laboratory Analysis

|February 9, 2002

Summary

National Institute of Standards and Technology (NIST) develops certified DNA standards for clinical laboratory analysis. These nucleic acid standards are crucial for quality assurance, standardization, and benchmarking diagnostic testing platforms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Progress and Future of US Newborn Screening.

International journal of neonatal screening·2022

Same author

Newborn screening for neurodevelopmental diseases: Are we there yet?

American journal of medical genetics. Part C, Seminars in medical genetics·2022

Same author

A Microcalorimeter for Measuring Self-Discharge of Pacemakers and Pacemaker Power Cells.

Journal of research of the National Bureau of Standards (1977)·2021

Same author

Correction to: ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Same author

ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Same author

Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Area of Science:

Biotechnology
Medical Diagnostics
Standards Development

Background:

Nucleic acid analysis is increasingly vital in clinical laboratories.
Standardized reagents and reliable standards are essential for accurate and reproducible testing.
Existing methods often rely on consensus guidelines from professional and governmental bodies.

Purpose of the Study:

To outline the National Institute of Standards and Technology's (NIST) experience and programs in developing national standards for DNA-based medical diagnostics.
To highlight the importance of benchmark reagents for standardization in clinical laboratory analysis.
To explain the role of NIST-certified DNA standards in supporting the diagnostic community and manufacturers.

Main Methods:

Development of NIST-certified DNA standards initiated through interdisciplinary workshops.

Related Experiment Videos

Focus on medically and biologically important analytes.

Leveraging NIST's expertise in developing physical and chemical standards.

Main Results:

NIST has established programs for the development of national DNA standards.
These standards serve as benchmarks for various DNA diagnostic testing platforms.
The initiative aims to promote automation and third-party reimbursement for clinical testing.

Conclusions:

NIST-certified DNA standards are critical for the standardization of clinical laboratory analysis.
These standards facilitate quality assurance, quality control, and proficiency testing.
The development of national nucleic acid standards by NIST supports the advancement of DNA-based medical diagnostics.